Darryl Geddes 315 464-4828
SUNY Upstate drug study seeks patients with Crohn’s disease
SYRACUSE, N.Y. – SUNY Upstate Medical University is seeking individuals with Crohn’s disease for a study testing the efficacy of the drug Leukine. Currently used in preventing infection in certain types of cancer therapy, Leukine helps stimulate immune cells that may be helpful in strengthening the immune system of the intestine.
The study seeks individuals over the age of 18 who have been diagnosed with moderate to severe Crohn’s disease. Subjects can be taking Mesalamine drugs, but cannot be on steroids or other immunosuppressants.
Crohn’s disease is a chronic inflammatory disease of the intestines. It primarily causes ulcerations in the small and large intestines, but can affect the digestive system anywhere between the mouth and the anus. Diarrhea, rectal bleeding and abdominal pain are frequent symptoms of Crohn’s disease.
For more information on the study, contact Kathy Moore at 464-9077.
Search Upstate News
Upstate in the News
- Parents urged to practice crib safety
News 10 Now
- Upstate Medical University opens new Neuroscience Research Building Monday
WSYR TV9 Syracuse
- Nosebleeds seldom need invasive treatment
- Cuomo: SUNY Upstate Medical University in Syracuse, other upstate schools win $2 million NIH grant
- NIH announced $2 million grant
News 10 Now
- SUNY Upstate Medical University leads six-school partnership that wins $2 million grant
Syracuse Post Standard